Adaptation of Bordetella pertussis to Vaccination: A Cause for Its Reemergence?

Abstract

In the Netherlands, as in many other western countries, pertussis vaccines have been used extensively for more than 40 years. Therefore, it is conceivable that vaccine-induced immunity has affected the evolution of Bordetella pertussis. Consistent with this notion, pertussis has reemerged in the Netherlands, despite high vaccination coverage. Further, a notable change in the population structure of B. pertussis was observed in the Netherlands subsequent to the introduction of vaccination in the 1950s. Finally, we observed antigenic divergence between clinical isolates and vaccine strains, in particular with respect to the surface-associated proteins pertactin and pertussis toxin. Adaptation may have allowed B. pertussis to remain endemic despite widespread vaccination and may have contributed to the reemergence of pertussis in the Netherlands.

References 16

1. 1.

   Andrews R., Herceg A., Roberts C. Pertussis notifications in Australia, 1991 to 1997. Commun Dis Intell. 1997;21(11):145-148.

   Not in our library10.33321/cdi.1997.21.30

2. 2.

   Cassiday P., Sanden G., Heuvelman K., Mooi F., Bisgard K. M., Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis. 2000;182(5):1402-1408.

   Not in our library10.1086/315881

3. 3.

   Cherry J. D. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis. 1999;28(Suppl 2):S112-S117.

   Not in our library10.1086/515058

4. 4.

   Cherry J. D., Gornbein J., Heininger U., Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine. 1998;16(20):1901-1906.

   Not in our library10.1016/s0264-410x(98)00226-6

5. 5.

   De Magistris M. T., Di Tommaso A., Domenighini M., Censini S., Tagliabue A., Oksenberg J. R., Steinman L., Judd A. K., O'Sullivan D., Rappuoli R. Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones. Proc Natl Acad Sci U S A. 1992;89(7):2990-2994.

   Not in our library10.1073/pnas.89.7.2990

6. 6.

   De Serres G., Boulianne N., Douville Fradet M., Duval B. Pertussis in Quebec: ongoing epidemic since the late 1980s. Can Commun Dis Rep. 1995;21(5):45-48.

   Not in our library

7. 7.

   Everest P., Li J., Douce G., Charles I., De Azavedo J., Chatfield S., Dougan G., Roberts M. Role of the Bordetella pertussis P.69/pertactin protein and the P.69/pertactin RGD motif in the adherence to and invasion of mammalian cells. Microbiology. 1996;142(Pt 11):3261-3268.

   Not in our library10.1099/13500872-142-11-3261

8. 8.

   Mastrantonio P., Spigaglia P., van Oirschot H., van der Heide H. G., Heuvelman K., Stefanelli P., Mooi F. R. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology. 1999;145(Pt 8):2069-2075.

   Not in our library10.1099/13500872-145-8-2069

9. 9.

   Mooi F. R., He Q., van Oirschot H., Mertsola J. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun. 1999;67(6):3133-3134.

   Not in our library10.1128/iai.67.6.3133-3134.1999

10. 10.

    Mooi F. R., van Oirschot H., Heuvelman K., van der Heide H. G., Gaastra W., Willems R. J. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun. 1998;66(2):670-675.

    Not in our library10.1128/iai.66.2.670-675.1998

11. 11.

    Nei M., Tajima F. DNA polymorphism detectable by restriction endonucleases. Genetics. 1981;97(1):145-163.

    Not in our library10.1093/genetics/97.1.145

12. 12.

    Ochman H., Wilson A. C. Evolution in bacteria: evidence for a universal substitution rate in cellular genomes. J Mol Evol. 1987;26(1-2):74-86.

    Not in our library10.1007/bf02111283

13. 13.

    Streisinger G., Owen J. Mechanisms of spontaneous and induced frameshift mutation in bacteriophage T4. Genetics. 1985;109(4):633-659.

    Not in our library10.1093/genetics/109.4.633

14. 14.

    Wright S. W., Decker M. D., Edwards K. M. Incidence of pertussis infection in healthcare workers. Infect Control Hosp Epidemiol. 1999;20(2):120-123.

    Not in our library10.1086/501593

15. 15.

    de Melker H. E., Conyn-van Spaendonck M. A., Rümke H. C., van Wijngaarden J. K., Mooi F. R., Schellekens J. F. Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis. 1997;3(2):175-178.

    Not in our library10.3201/eid0302.970211

16. 16.

    van Loo I. H., van der Heide H. G., Nagelkerke N. J., Verhoef J., Mooi F. R. Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J Infect Dis. 1999;179(4):915-923.

    Not in our library10.1086/314690

Cited by papers we hold 5

• Asymptomatic transmission and the resurgence of Bordetella pertussis · 2015
  No notice
• The adaptive evolution of virulence: a review of theoretical predictions and empirical tests · 2015
  No notice
• Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis · 2010
  No notice
• Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. · 2010
  Not checked
• Bordetella pertussis, the Causative Agent of Whooping Cough, Evolved from a Distinct, Human-Associated Lineage of B. bronchiseptica · 2005
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.